Patents Assigned to Advanced Life Science Institute, Inc.
  • Patent number: 7316905
    Abstract: A method for measurement of the hepatitis C virus (HCV) characterized by measuring HCV core antigen and HCV core antibody by their binding with probes in the presence of an anionic surfactant or a non-ionic surfactant, or both.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: January 8, 2008
    Assignee: Advanced Life Science Institute, Inc.
    Inventors: Katsumi Aoyagi, Chiharu Ohue, Kumiko Iida, Shintaro Yagi
  • Publication number: 20070264646
    Abstract: Hepatitis B virus (HBV) particles that contain HBV-RNA but do not contain HBV-DNA in a body fluid sample; A method of measuring the particles according to claim 1 by measuring HBV-RNA; A method of judging the therapeutic effect of the treatment of HBV infections by a drug having an effect of inhibiting RNA-dependent DNA polymerase, which method comprises performing the measurement on a body fluid of a patient who received said treatment; A method of predicting the risk of developing hepatic carcinoma or selecting risk groups of developing hepatic carcinoma by the above measurement.
    Type: Application
    Filed: June 22, 2004
    Publication date: November 15, 2007
    Applicant: Advanced Life Science Institute, Inc.
    Inventors: Noboru Maki, Tatsuji Kimura, Akihiro Matsumoto, Akinori Rokuhara, Eiji Tanaka, Kendo Kiyosawa
  • Patent number: 6623921
    Abstract: A method for measurement of the hepatitis C virus (HCV) characterized by measuring HCV core antigen and HCV core antibody by their binding with probes in the presence of an anionic surfactant or a non-ionic surfactant, or both.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: September 23, 2003
    Assignee: Advanced Life Science Institute, Inc.
    Inventors: Katsumi Aoyagi, Chiharu Ohue, Kumiko Iida, Shintaro Yagi
  • Publication number: 20020173493
    Abstract: A method for measurement of the hepatitis C virus (HCV) characterized by measuring HCV core antigen and HCV core antibody by their binding with probes in the presence of an anionic surfactant or a non-ionic surfactant, or both.
    Type: Application
    Filed: April 26, 2002
    Publication date: November 21, 2002
    Applicant: ADVANCED LIFE SCIENCE INSTITUTE, INC.
    Inventors: Katsumi Aoyagi, Chiharu Oheu, Kumiko Iida, Shintaro Yagi
  • Patent number: 6322965
    Abstract: A chimera antigen peptide containing the epitope regions in the core region, the NS3 region, and the NS4 region of the HCV polypeptide. A sensitive detection of a wide range of infection by hepatitis C virus (HCV) can be carried out.
    Type: Grant
    Filed: February 9, 1998
    Date of Patent: November 27, 2001
    Assignee: Advanced Life Science Institute, Inc.
    Inventors: Kenjiro Yamaguchi, Tomiko Kashiwakuma, Yukie Chiba, Shintaro Yagi, Akira Hasegawa
  • Patent number: 6313267
    Abstract: A bovine- or human-derived calcium-binding protein with a prescribed amino acid sequence, a method for its production, and antibodies against the protein and uses thereof.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: November 6, 2001
    Assignee: Advanced Life Science Institute, Inc.
    Inventors: Jiro Hitomi, Ken Yamaguchi, Tokujiro Yamamura, Tatsuji Kimura